BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11528583)

  • 1. Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment.
    Marovich MA; Lira R; Shepard M; Fuchs GH; Kruetzer R; Nutman TB; Neva FA
    Clin Infect Dis; 2001 Oct; 33(7):1076-9. PubMed ID: 11528583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR; Weerakoon HS
    J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
    Hartzell JD; Aronson N
    N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous leishmaniasis: successful treatment with itraconazole.
    Consigli J; Danielo C; Gallerano V; Papa M; Guidi A
    Int J Dermatol; 2006 Jan; 45(1):46-9. PubMed ID: 16426375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of localized cutaneous leishmaniasis].
    Buffet P; Caumes E; Gentilini M
    Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
    [No Abstract]   [Full Text] [Related]  

  • 7. Leishmaniasis recidivans in a Palestinian Bedouin child.
    Al-Jawabreh A; Nasereddin A
    Skinmed; 2007; 6(5):250-2. PubMed ID: 17786107
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous ulcer in a man returning from Central America.
    Haider S; Boutross-Tadross O; Radhi J; Momar N
    CMAJ; 2003 Mar; 168(5):590-1. PubMed ID: 12615757
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous leishmaniasis treated with itraconazole.
    Baroni A; Aiello FS; Vozza A; Vozza G; Faccenda F; Brasiello M; Ruocco E
    Dermatol Ther; 2009 Nov; 22 Suppl 1():S27-9. PubMed ID: 19891689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
    Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
    J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milia and cutaneous leishmaniasis.
    Del Giudice P
    Br J Dermatol; 2007 May; 156(5):1088. PubMed ID: 17381448
    [No Abstract]   [Full Text] [Related]  

  • 12. A successful treatment of a Kenyan case of unresponsive cutaneous leishmaniasis with a combination of pentostam and oral allopurinol: case report.
    Kirigi G; Mbuchi MW; Mbui JK; Rashid JR; Kinoti DM; Njoroge SN; Basiye F; Magiri C; Wasunna MK
    East Afr Med J; 2010 Dec; 87(12):521-4. PubMed ID: 23457863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of ocular leishmaniasis.
    Abrishami M; Soheilian M; Farahi A; Dowlati Y
    Eur J Dermatol; 2002; 12(1):88-9. PubMed ID: 11809607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leishmaniasis: three children with Leishmania major successfully treated with itraconazole.
    White JM; Salisbury JR; Jones J; Higgins EM; Vega-Lopez F
    Pediatr Dermatol; 2006; 23(1):78-80. PubMed ID: 16445420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster virus--specific immune response after treatment with sodium stibogluconate for cutaneous leishmaniasis.
    Yoon IK; Cox J; Zhou Y; Lukes Y; Reinhardt B; Valencia-Micolta A; Wortmann G
    Am J Trop Med Hyg; 2008 Mar; 78(3):402-5. PubMed ID: 18337334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection.
    Gilad J; Borer A; Hallel-Halevy D; Riesenberg K; Alkan M; Schlaeffer F
    Isr Med Assoc J; 2001 Jun; 3(6):451-2. PubMed ID: 11433642
    [No Abstract]   [Full Text] [Related]  

  • 19. Case 2. Lupoid leishmaniasis.
    Bowling JC; Vega-Lopez F
    Clin Exp Dermatol; 2003 Nov; 28(6):683-4. PubMed ID: 14616851
    [No Abstract]   [Full Text] [Related]  

  • 20. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
    Yardley V; Ortuno N; Llanos-Cuentas A; Chappuis F; Doncker SD; Ramirez L; Croft S; Arevalo J; Adaui V; Bermudez H; Decuypere S; Dujardin JC
    J Infect Dis; 2006 Oct; 194(8):1168-75. PubMed ID: 16991093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.